Patients who once relied on heavy narcotics to treat their suffering are turning to costly surgical implants instead
Like millions of people caught up in America’s opioid crisis, Rick Surkin used to take a pill just to get out of bed in the morning. Until last year, the former firefighter relied on thrice-daily doses of the powerful painkiller OxyContin to numb the agony from a ruptured disc in his back. “You can take enough pills to mask the pain, but they take over your life,” he says. He’s been able to get back on his surfboard, and into the California surf shop he manages, because a medical implant sends 10,000 pulses of low-voltage electricity through his spine per second.
The series of tiny shocks, known as neuro modulation, has kept Surkin comfortable enough to ditch Oxy. “There is a lot more time I’m pain-free now,” he says. That allowed the 64-year-old to resume his outdoorsy lifestyle, and the benefits are more than just physical: His increased energy and better moods have helped revive his relationship with his wife. “I’m back to the person she married,” he says.
After a half-century on the fringes of medical science, neuro modulation is becoming a mainstream alternative to painkillers for those who can afford it. Sales of spinal stimulators, used mainly to soothe nerve pain in legs and backs, rose 20 percent, to $1.8 billion, in the U.S. last year. Doctors see potential for similar therapies to treat migraines, neck pain, and other ailments that afflict millions. “Particularly as opioids are being limited, you want physicians to have an option that gives this sort of an impact,” says Rami Elghandour, chief executive officer of Nevro Corp., the maker of Surkin’s implant.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Golfing With The Enemy
Did Donald Trump's executives violate the Cuban embargo?
Super-Rich Syrians Wait for War's End
Actor, author, playwright. Gill Pringle tries her hand at unravelling the mystery behind this enigmatic multi-hyphenate
Pam Codispoti
The mastermind behind the industry-shaping Chase Sapphire Reserve Card sets her sights on banking
This Time It's The Economy
President Rouhani’s budget sets offprotests from people angry about unemployment and inflation
Saudi Prince Counts On Support Of Citizens
State-worker salary increases appeal to the people, but policy may throw the budget off track
Stalin's Legacy Is Choking The Ukrainian Economy
The government has resisted pressure to lift a ban on land sales, despite pressure from the IMF and investors
Catastrophe Bonds Survive A Stormy Year
The turbulence of 2017 couldn’t destroy a market for betting against disasters
Riding The West Bank's Credit Boom
Increased consumer lending is creating a bubble in the West Bank
You'd Be Crazy To Buy Pizza With Bitcoin
Speculative fervour makes the cryptocurrency clumsy for commerce
What If The President Loses His Party?
Trump has to figure out a way to work with Republicans in Congress, or the global economy may be at stake